Literature DB >> 18191408

The role of interleukin-22 in hepatitis C virus infection.

Julia Dambacher1, Florian Beigel, Kathrin Zitzmann, Malte H J Heeg, Burkhard Göke, Helmut M Diepolder, Christoph J Auernhammer, Stephan Brand.   

Abstract

In this study, we analyzed if IL-22 displays, similar to other IL-10 like cytokines such as IL-28A, antiviral properties in hepatic cells. Using RT-PCR and immunoblotting, we demonstrated that hepatic cell lines and primary hepatocytes express the functional IL-22 receptor complex consisting of IL-22R1 and IL-10R2. Hepatic IL-22 mRNA expression as measured by quantitative PCR was up-regulated in autoimmune and viral hepatitis compared to cholestatic liver diseases, while IL-22 serum levels did not differ significantly between patients with viral hepatitis and normal controls. IL-22 did not significantly change the expression levels of IFN-alpha/-beta and of the antiviral proteins MxA and 2',5'-OAS. Consequently, it had in comparison to IFN-alpha no relevant antiviral activity in in vitro models of HCV replication and infection. Taken together, hepatic IL-22 expression is up-regulated in viral hepatitis but IL-22 does not directly regulate antiviral proteins and has, in contrast to IFN-alpha, no effect on HCV replication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18191408     DOI: 10.1016/j.cyto.2007.11.016

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  41 in total

1.  Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Authors:  Christophe Paget; Stoyan Ivanov; Josette Fontaine; Joelle Renneson; Fany Blanc; Muriel Pichavant; Laure Dumoutier; Bernhard Ryffel; Jean Christophe Renauld; Philippe Gosset; Pierre Gosset; Mustapha Si-Tahar; Christelle Faveeuw; François Trottein
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

2.  Acute and chronic effects of IL-22 on acetaminophen-induced liver injury.

Authors:  Dechun Feng; Yan Wang; Hua Wang; Honglei Weng; Xiaoni Kong; Brittany V Martin-Murphy; Yongmei Li; Ogyi Park; Steven Dooley; Cynthia Ju; Bin Gao
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

3.  Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment.

Authors:  Juanjuan Zhao; Zheng Zhang; Yan Luan; Zhengsheng Zou; Yanling Sun; Yonggang Li; Lei Jin; Chunbao Zhou; Junliang Fu; Bin Gao; Yangxin Fu; Fu-Sheng Wang
Journal:  Hepatology       Date:  2014-03-01       Impact factor: 17.425

4.  Regulatory role of CD4(+)CD25 (+)Foxp3 (+) regulatory T cells on IL-17-secreting T cells in chronic hepatitis B patients.

Authors:  Jie Li; Jun Shi; Wanhua Ren; Wei Wu; Zhi Chen
Journal:  Dig Dis Sci       Date:  2014-01-18       Impact factor: 3.199

5.  A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus.

Authors:  Ye Zhang; Melissa A Cobleigh; Jian-Qi Lian; Chang-Xing Huang; Carmen J Booth; Xue-Fan Bai; Michael D Robek
Journal:  Gastroenterology       Date:  2011-06-25       Impact factor: 22.682

6.  Retinoic Acid Regulates Immune Responses by Promoting IL-22 and Modulating S100 Proteins in Viral Hepatitis.

Authors:  Zuliang Jie; Yuejin Liang; Panpan Yi; Hui Tang; Lynn Soong; Yingzi Cong; Kangling Zhang; Jiaren Sun
Journal:  J Immunol       Date:  2017-03-31       Impact factor: 5.422

Review 7.  Targeting IL-10 Family Cytokines for the Treatment of Human Diseases.

Authors:  Xiaoting Wang; Kit Wong; Wenjun Ouyang; Sascha Rutz
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-02-01       Impact factor: 10.005

8.  Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.

Authors:  Amanda B Macedo; Camille L Novis; Caroline M De Assis; Eric S Sorensen; Paula Moszczynski; Szu-Han Huang; Yanqin Ren; Adam M Spivak; R Brad Jones; Vicente Planelles; Alberto Bosque
Journal:  JCI Insight       Date:  2018-10-04

9.  Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus.

Authors:  Julia Diegelmann; Florian Beigel; Kathrin Zitzmann; Artur Kaul; Burkhard Göke; Christoph J Auernhammer; Ralf Bartenschlager; Helmut M Diepolder; Stephan Brand
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

10.  Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.

Authors:  Stoyan Ivanov; Joelle Renneson; Josette Fontaine; Adeline Barthelemy; Christophe Paget; Elodie Macho Fernandez; Fany Blanc; Carl De Trez; Laurye Van Maele; Laure Dumoutier; Michel-René Huerre; Gérard Eberl; Mustapha Si-Tahar; Pierre Gosset; Jean Christophe Renauld; Jean Claude Sirard; Christelle Faveeuw; François Trottein
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.